Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 ,inter alia, to consider and approve Unaudited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Venmax Drugs and Pharmaceuticals has informed BSE that its Board of Directors will meet on Saturday, February 7, 2026 at 4:00 PM. The main agenda is to consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2025. The company has also confirmed that the trading window for designated persons remains closed and will stay closed until 48 hours after the results are approved on February 7, 2026. This is a standard regulatory intimation under SEBI LODR Regulation 29 ahead of the Q3 earnings announcement.
No direct impact on shareholders from this intimation itself, but the February 7 meeting will reveal the company's Q3 FY26 earnings performance, which could move the stock once results are announced.